E.g., 06/23/2024
E.g., 06/23/2024
Titlesort ascending Category Credit Event date Price
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Oral Board Study Guide App (2023) (iOS and Android) $299.00 The AUA Oral Board Study Guide App features 78 interactive protocols in 37 topic areas. Developed by leading experts in urology, the app has been specifically designed for urologists preparing to take this examination and includes a strong emphasis on AUA Guidelines with direct access to the AUA Guidelines and the AUA Urology Core Curriculum for AUA members. Available for use on Apple and Android devices! Simply purchase access from AUA, download the app and then sign in with your AUA ID number.
Novel Imaging for Genitourinary Cancers – Diagnostics and Theranostics Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence.
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will focus on specific topics discussed in the recent AUA Practice Guidelines for non-muscle invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC.
Life Long Learning Prep Course Webcast: Module 4: Office Based Urology (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 3: Impotence, Infertility and Andrology (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 2: Calculi, Laparoscopy-Robotics and Upper Tract Obstruction (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 1: Oncology, Urinary Diversion and Adrenal (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Integrating Biomarkers into Bladder Cancer Clinical Trials (2024) 03/15/2024 $260.00 Johns Hopkins Greenberg Bladder Cancer Institute and American Urological Association Translational Research CollaborationIntegrating Biomarkers into Bladder Cancer Clinical Trials (2024) will be held in-person, March 15-16, 2024 at AUA Headquarters in Linthicum, MD.
Institute for Leadership & Business (ILB) Track On-Demand (2023) $470.00 Invest in your leadership and business skills with the Institute for Leadership & Business (ILB) Track On-Demand. The ILB Track features 15 hours of programming that will enhance your business skills, activate your interest in business and finance, and inspire the leader in you!
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 This new AUAUniversity podcast episode will address mechanisms behind infectious complications as well as the health care consequences of infections following prostate biopsy. Faculty will present real world and trial data pertaining to rates and associated factors for infections and provide practical measures to reduce these complications, including transperineal and transrectal approach (standard enema; antibiotic enema; iodine/other rectal prep; needle disinfection).
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.  
Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There are multiple genomic tests and advanced imaging modalities (MRI, prostate-specific membrane antigen PET, etc.) currently available for men to detect and risk-stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc.) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc.). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling and cascade testing of family members.
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local...
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The learners will understand the following critical clinical aspects with regard to the clinical application of prostate-specific membrane antigen (PSMA) PET/CT; scanning mode of action of PSMA PET/CT; pitfalls of PSMA PET/CT; diagnostic accuracy depending on PSA, PSA double time, prostate cancer histology; application of PSMA PET/CT to identify patients with intrapelvic nodal relapse who will benefit from local therapy such as salvage lymphadenectomy or stereotactic radiation therapy; application of PSMA PET/CT to identify patients with organ-confined radiorecurrent local relapse of prosta

Pages